SCHEMBL6971871

SCHEMBL6971871

CC(=O)c1ccc2c(c1)c1cccc3c1n2CCC3=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 1/20 0.44
ALDH1A1 P00352 4/20 0.41
HPGD P15428 3/20 0.41
TP53 P04637 1/20 0.38
ALOX5 P09917 1/20 0.38
S100A4 P26447 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
ALOX15 P16050 1/20 0.37
ALOX12 P18054 1/20 0.37
MAPK1 P28482 1/20 0.37
CASP1 P29466 1/20 0.37
KMT2A Q03164 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13703800 0.86 MAPT (0.43) MAPTSMN1; SMN2LMNAALDH1A1HPGD
SCHEMBL13703670 0.81 MAPT (0.39) MAPTSMN1; SMN2LMNAALDH1A1HPGD
SCHEMBL6977937 0.79 MEN1 (0.40) MAPTSMN1; SMN2LMNAALDH1A1HPGD
SCHEMBL6982876 0.79 MAPT (0.36) MAPTSMN1; SMN2LMNAALDH1A1HPGD
SCHEMBL6981939 0.78 PIM1 (0.42) MAPTALDH1A1HPGDKDM4EMEN1
SCHEMBL13703612 0.78 MAPT (0.36) MAPTSMN1; SMN2LMNAALDH1A1HPGD
SCHEMBL13703797 0.78 MAPT (0.39) MAPTSMN1; SMN2LMNAALDH1A1HPGD
SCHEMBL13703639 0.77 MAPT (0.36) MAPTSMN1; SMN2LMNAALDH1A1HPGD
SCHEMBL7670693 0.73 SMARCA4 (0.41) ALDH1A1HPGDKDM4EHSD17B10
SCHEMBL13703593 0.72 MAPT (0.38) MAPTSMN1; SMN2LMNAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed